Biotechnology company Amgen has agreed to acquire Teneobio, a privately held clinical stage biotechnology firm, in a deal valued at about $900m.
Read More at:
https://www.pharmaceutical-business-review.com/news/amgen-acquire-biotechnology-firm-teneobio/
Copyright © PassionIT News.com
All right Reserved 2020